J&J Unit Scores $1.2B Judgment In Stent Feud
After a decade-long battle over its balloon expandable stent technology, a unit of Johnson & Johnson has landed a $1.2 billion final judgment against Boston Scientific Corp. and Medtronic Inc....To view the full article, register now.
Already a subscriber? Click here to view full article